Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Journal of Southern Medical University ; (12): 2440-2442, 2010.
Article in Chinese | WPRIM | ID: wpr-323641

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of resveratrol bovine serum albumin nanoparticles on SKOV3 cell line and its mechanisms.</p><p><b>METHODS</b>The morphological changes of the cells exposed to the nanoparticles were observed by apoptotic body/cell nucleus DNA staining under inverted microscope and fluorescence microscope, and the pathway of cell death was determined by phosphatidylserine translocation. Western blotting was performed to detect the activation of cyto.c, caspase-3 and caspase-9.</p><p><b>RESULTS</b>DNA ladder was detected with gel electrophoresis and the cell death was partially inhibited by the pan-caspase inhibitor Z-VAD-FMK. Gel electrophoresis displayed both DNA ladder and smear in RES-BSANP exposed groups, while DNA ladder disappeared in Z-VAD-FMK group and only the smear was left. Cyto.c in the cytoplasm was released at 2 h, while the expression of caspase-9 protein reached the peak level at 4 h and caspase-3 expression was obvious enhanced at 8 h. At 4 h, caspase-9 expression in the cells exposed to 100 µmol/L RES-BSANP was decreased significantly as compared to the cells treated with 50 µmol/L RES-BSANP (P>0.05).</p><p><b>CONCLUSION</b>RES-BSANP can induce the necrosis and apoptosis of SKOV3 cells via either caspase-dependent or caspase-independent pathways.</p>


Subject(s)
Female , Humans , Apoptosis , Caspase 3 , Metabolism , Caspase 9 , Metabolism , Cell Death , Cell Line, Tumor , Cytochromes c , Metabolism , Nanoparticles , Ovarian Neoplasms , Pathology , Stilbenes , Pharmacology
2.
Chinese Journal of Oncology ; (12): 170-173, 2008.
Article in Chinese | WPRIM | ID: wpr-348140

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the anti-angiogenic activity of peptide 21 obtained by modification of tumstatin, and its inhibitory effect on the growth and metastasis of human ovarian cancer transplanted in nude mice.</p><p><b>METHODS</b>The peptide 21 was purified by affinity chromatography. Human ovarian cancer SKOV3 cells were inoculated in nude mice and the transplanted tumor was treated with the peptide 21 to observe the tumor growth and metastasis. The microvessel density (MVD) and immunohistochemical staining index of PCNA, VEGF and MMP-2 and TIMP-2 were performed to assess the inhibitory effect of the peptide 21.</p><p><b>RESULTS</b>In the nude mice at 21 days after peptide 21 treatment, the inhibition rate of tumor growth was 53.17%, the tumor microvessel density was significantly reduced (P <0.05), the expression of PCNA, VEGF and MMP-2 were significantly lower (P <0.01), and TIMP-2 expression was significantly higher (P <0.01) in comparison with that of control group.</p><p><b>CONCLUSION</b>The peptide 21 generated in this study has a significant anti-angiogenetic activity, showing significant inhibitory effect on the growth of human ovarian cancer transplanted in nude mice. The mechanism of its inhibitory action on ovarian cancer growth may be mediated by reduction of neovascularization and reduction of expression of angiogenetic factors.</p>


Subject(s)
Animals , Female , Humans , Mice , Angiogenesis Inhibitors , Chemistry , Pharmacology , Antigens, CD34 , Metabolism , Antineoplastic Agents , Chemistry , Pharmacology , Autoantigens , Chemistry , Pharmacology , Cell Line, Tumor , Collagen Type IV , Chemistry , Pharmacology , Matrix Metalloproteinase 2 , Metabolism , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Neovascularization, Pathologic , Pathology , Ovarian Neoplasms , Metabolism , Pathology , Peptides , Chemistry , Pharmacology , Proliferating Cell Nuclear Antigen , Metabolism , Recombinant Proteins , Chemistry , Pharmacology , Tissue Inhibitor of Metalloproteinase-2 , Metabolism , Tumor Burden , Vascular Endothelial Growth Factor A , Metabolism , Xenograft Model Antitumor Assays
3.
Chinese Journal of Epidemiology ; (12): 622-625, 2005.
Article in Chinese | WPRIM | ID: wpr-331821

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the correlation between genesis and the development of cervical cancer and infection of human papillomavirus (HPV) type 16/18, human herpesvirus II (HSV- II) and cytomegalovirus(CMV).</p><p><b>METHODS</b>Different viruses were determined by polymerase chain reaction in 156 specimens of uterine including cervix 43 cervical cancer specimens,47 cervical intraepithelial neoplasia (CIN) specimens, 56 cervicitis specimens and 10 normal cervix specimens.</p><p><b>RESULTS</b>(1) Positive rates on different viruses: the positive rates of HSV- II, HPV16/18 and CMV were declining in the cervical cancer specimens, CIN specimens or CIN III specimens and CIN I - II specimens, with significant differences. (2)Positive rate and grading, staging and histogenesis of cervical cancer on different viruses as well as positive rates of HPV16/18 in II staging cervical cancer specimens were significantly higher than that in I staging cervical cancer specimens while positive rates of HPV16/18 and HSV- II in high differentiation of cervical cancer specimens were significantly higher than those with medium differentiation from cervical cancer specimens. Positive rates of CMV did not seem to correlate with positive rate of HSV- II and CMV was not correlated to grading, staging or histogenesis of cervical cancer. (3)Copies of infected virus, HSV-II and HPV16/18 showing cervical cancer>CIN> cervicitis while with CMV:cervical cancer>CIN. (4) There were mixed infections of different viruses as HPV16/18 + HSV- II > HPV16/18 + CMV seen in the study.</p><p><b>CONCLUSION</b>HPV 16/18, HSV- II and CMV infection were closely related to the genesis of cervical cancer and quantity of viruses which might have played an important role in carcinogenesis of cervical lesions.</p>


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Case-Control Studies , Cell Differentiation , Cytomegalovirus , Physiology , Cytomegalovirus Infections , Disease Progression , Herpes Genitalis , Herpesvirus 2, Human , Physiology , Human papillomavirus 16 , Physiology , Human papillomavirus 18 , Physiology , Neoplasm Staging , Papillomavirus Infections , Uterine Cervical Neoplasms , Pathology , Virology
4.
Chinese Medical Sciences Journal ; (4): 125-129, 2004.
Article in English | WPRIM | ID: wpr-254009

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the role of extracellular regulated kinase (ERK1/2) pathway in cisplatin-induced apoptosis in human ovarian carcinoma cells.</p><p><b>METHODS</b>Cisplatin-induced apoptosis were stained with DAPI and was assessed microscopically in human epithelial adenocarcinoma ovarian cell line SKOV3 cells. ERK activation was determined by Western blotting using an anti-phospho-ERK antibody to detect ERK activity. The effect of PD98059 on ERK activity induced by cisplatin was detected by MTT assay.</p><p><b>RESULTS</b>Marked apoptosis of SKOV3 cells resulted from 48 hours treatment with 20 microg/mL cisplatin. Strong activation of ERK was led to by 15 microg/mL cisplatin. Dose response and time course of cisplatin induced apoptosis in SKOV3 cells. Cisplatin-induced ERK activation occurred at 12 hours and increased to highest induction at 24 hours by Western blotting. The effect of PD 98059 on ERK activity induced by cisplatin at the concentration of 100 micromol/L PD 98059. Statistically significant decreased in cell survival were observed with 100 micromol/L PD 98059 at 15 and 20 microg/mL cisplatin (P < 0.05).</p><p><b>CONCLUSIONS</b>Cisplatin activates the ERK signaling pathway in ovarian cancer cell line SKOV3. Inhibition of ERK activity enhances sensitivity to cisplatin cytotoxity in ovarian cancer cell line SKOV3. Evaluation of ERK activity could be useful in predicting which ovarian cancer will response most favorably to cisplatin therapy.</p>


Subject(s)
Female , Humans , Adenocarcinoma , Pathology , Antineoplastic Agents , Pharmacology , Apoptosis , Cell Line, Tumor , Cell Survival , Cisplatin , Pharmacology , Enzyme Activation , Flavonoids , Pharmacology , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases , Metabolism , Ovarian Neoplasms , Pathology , Signal Transduction
5.
Chinese Journal of Epidemiology ; (12): 924-927, 2003.
Article in Chinese | WPRIM | ID: wpr-246428

ABSTRACT

<p><b>OBJECTIVE</b>To define a correlation between different human papillomavirus (HPV) types and telomerase activity in cervical cancer.</p><p><b>METHODS</b>Telomerase activity was detected by TRAP-PCR, and different HPV type was determined by PCR in 83 cervical cancer, 47 cervical intraepithelial neoplasia (CIN) and 10 normal cervix cases.</p><p><b>RESULTS</b>With regard to positive rates of telomerase and HPV 16/18: the results were cervical cancer > CIN > normal cervix, CIN III > CIN I, II; with regard to HPV 6/11 positive rate: the results showed CIN I, II > CIN III. Positive rates of telomerase cervical cancer and HPV were bearing on grading and staging, but they did not correlate with histologic subtypes. Positive rate of HPV 6/11 had nothing to do with grading, staging and histologic patterns. On expression strength of telomerase and HPV 16/18: the results showed cervical cancer > CIN, CIN III > CIN I, II. Regard to HPV 6/11'expression strength: the results showed CIN I, II > CIN III, CIN > cervical carcinoma.</p><p><b>CONCLUSION</b>HPV 16/18 infection seemed to have played an important role in carcinogenesis of cervical lesions by activation of telomerase.</p>


Subject(s)
Female , Humans , Uterine Cervical Dysplasia , Pathology , Virology , Neoplasm Staging , Papillomaviridae , Telomerase , Metabolism , Uterine Cervical Neoplasms , Pathology , Virology
SELECTION OF CITATIONS
SEARCH DETAIL